Tectonic Therapeutic, Inc. (TECX) stock
TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$21.04−0.92 (-4.19%)
Close on Nov 12, 2026Market cap $411.32MP/E –Yield 0.00%
Tectonic Therapeutic total assets
Total assets on the balance sheet at the end of each period.
Tectonic Therapeutic's total assets was $243.86M at Sep 30, 2026. For fiscal 2025 it was $261.04M, up 70.7% from the year before. The highest annual figure on record is $271.23M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $261.04M | +70.7% |
| FY2024 | Dec 31, 2024 | $152.91M | +288.1% |
| FY2023 | Dec 31, 2023 | $39.40M | -62.1% |
| FY2022 | Dec 31, 2022 | $103.95M | -49.0% |
| FY2021 | Dec 31, 2021 | $203.84M | -24.8% |
| FY2020 | Dec 31, 2020 | $271.23M | +35.3% |
| FY2019 | Dec 31, 2019 | $200.51M | +50.2% |
| FY2018 | Dec 31, 2018 | $133.48M | +1800.9% |
| FY2017 | Dec 31, 2017 | $7.02M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $243.86M | -12.0% |
| Q2 FY2026 | Jun 30, 2026 | $237.03M | -19.7% |
| Q1 FY2026 | Mar 31, 2026 | $246.58M | -21.7% |
| Q4 FY2025 | Dec 31, 2025 | $261.04M | +70.7% |
| Q3 FY2025 | Sep 30, 2025 | $277.00M | +64.2% |
| Q2 FY2025 | Jun 30, 2025 | $295.31M | +52.3% |
| Q1 FY2025 | Mar 31, 2025 | $314.83M | +240.9% |
| Q4 FY2024 | Dec 31, 2024 | $152.91M | +288.1% |
| Q3 FY2024 | Sep 30, 2024 | $168.72M | +52.7% |
| Q2 FY2024 | Jun 30, 2024 | $193.91M | +44.9% |
| Q1 FY2024 | Mar 31, 2024 | $92.35M | +11.3% |
| Q4 FY2023 | Dec 31, 2023 | $39.40M | -62.1% |
| Q3 FY2023 | Sep 30, 2023 | $110.52M | -14.7% |
| Q2 FY2023 | Jun 30, 2023 | $133.84M | -8.5% |
| Q1 FY2023 | Mar 31, 2023 | $83.01M | -52.7% |
| Q4 FY2022 | Dec 31, 2022 | $103.95M | -49.0% |
| Q3 FY2022 | Sep 30, 2022 | $129.50M | -40.2% |
| Q2 FY2022 | Jun 30, 2022 | $146.24M | -38.6% |
| Q1 FY2022 | Mar 31, 2022 | $175.34M | -28.7% |
| Q4 FY2021 | Dec 31, 2021 | $203.84M | -24.8% |
| Q3 FY2021 | Sep 30, 2021 | $216.45M | -7.2% |
| Q2 FY2021 | Jun 30, 2021 | $238.10M | -6.8% |
| Q1 FY2021 | Mar 31, 2021 | $245.91M | -8.8% |
| Q4 FY2020 | Dec 31, 2020 | $271.23M | +35.3% |
| Q3 FY2020 | Sep 30, 2020 | $233.26M | +7.4% |
| Q2 FY2020 | Jun 30, 2020 | $255.57M | +150.6% |
| Q1 FY2020 | Mar 31, 2020 | $269.73M | +129.8% |
| Q4 FY2019 | Dec 31, 2019 | $200.51M | +50.2% |
| Q3 FY2019 | Sep 30, 2019 | $217.21M | +51.6% |
| Q2 FY2019 | Jun 30, 2019 | $101.99M | -35.7% |
| Q1 FY2019 | Mar 31, 2019 | $117.37M | +1571.4% |
| Q4 FY2018 | Dec 31, 2018 | $133.48M | – |
| Q3 FY2018 | Sep 30, 2018 | $143.27M | – |
| Q2 FY2018 | Jun 30, 2018 | $158.73M | – |
| Q4 FY2017 | Dec 31, 2017 | $7.02M | – |
See a number that looks wrong?